Get the Stockscreener App
2.44
3.56%
-0.09
After Hours:
2.42
-0.02
-0.82%
Reshape Lifesciences Inc stock is traded at $2.44, with a volume of 85,039.
It is down -3.56% in the last 24 hours and up +0.00% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
See More
Previous Close:
$2.53
Open:
$2.45
24h Volume:
85,039
Relative Volume:
0.03
Market Cap:
$3.25M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0629
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
-10.62%
1M Performance:
+0.00%
6M Performance:
-97.41%
1Y Performance:
-99.14%
1-Day Range:
$2.43
$2.5294
1-Week Range:
$2.31
$2.73
52-Week Range:
$2.23
$303.25
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Compare RSLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
2.44 | 6.04M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Reshape Lifesciences Inc Stock (RSLS) Latest News
What is the dividend policy of ReShape Lifesciences Inc. stockPost Market Trend Scanner For Smart Trading - jammulinksnews.com
What are ReShape Lifesciences Inc. company’s key revenue driversFree Stock Review Backed By Experts - jammulinksnews.com
Is ReShape Lifesciences Inc. a growth stock or a value stockExpert Picks Review With Low Risk - jammulinksnews.com
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionLow Risk Picks for Daily Trading Released - beatles.ru
ReShape Lifesciences Inc. Pullback Analyzed — Is It Time to ExitAI Forecast for Trending Stocks Indicates Upside - metal.it
ReShape Lifesciences Inc. Forms Double Bottom Pattern — Eyes on BreakoutWatchlist for Smart Swing Trading Updated - metal.it
Published on: 2025-07-29 19:35:19 - metal.it
Options Data Show Bullish Bias in ReShape Lifesciences Inc.Pattern Alert With ROI Driven Strategy Shared - metal.it
ReShape Lifesciences Inc. Inches Toward Key Resistance — Will It BreakReal Trader Watchlist of Hot Stocks Released - metal.it
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
What are the latest earnings results for ReShape Lifesciences Inc.Achieve breakthrough profits with smart strategies - jammulinksnews.com
How strong is ReShape Lifesciences Inc. company’s balance sheetUnprecedented profits - jammulinksnews.com
How does ReShape Lifesciences Inc. generate profit in a changing economyAchieve impressive returns with smart timing - jammulinksnews.com
Is it the right time to buy ReShape Lifesciences Inc. stockBuild wealth faster with consistent growth stocks - jammulinksnews.com
What are the technical indicators suggesting about ReShape Lifesciences Inc.Gain insights from top financial experts - jammulinksnews.com
ReShape Lifesciences Holds Special Stockholder Meeting - TipRanks
ReShape Lifesciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - Autocar Professional
What drives ReShape Lifesciences Inc. stock priceTremendous growth potential - PrintWeekIndia
What analysts say about ReShape Lifesciences Inc. stockPhenomenal capital appreciation - Autocar Professional
Will ReShape Lifesciences Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com
ReShape Lifesciences Announces Partial Adjournment of Stockholder Meeting for Asset Sale and Charter Amendment Proposals - Nasdaq
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire
ReShape Lifesciences Merger at Critical Stage: Stockholders Must Approve Asset Sale by August 7 - Stock Titan
ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest
Is ReShape Lifesciences Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire
ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga
ReShape Lifesciences Strategic Transformation: Board and Proxy Advisors Unite Behind Vyome Merger - Stock Titan
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):